TLR4 agonist for short-term prophylaxis of respiratory viral infections in allergic type of immune response

被引:0
|
作者
Nikonova, A. A. [1 ]
Pichugin, A., V [1 ]
Chulkina, M. M. [1 ]
Gaysina, A. R. [1 ]
Shilovskiy, I. P. [1 ]
Ataullakhanov, R., I [1 ]
Khaitov, R. M. [1 ]
Khaitov, M. R. [1 ]
机构
[1] NRC Inst Immunol FMBA, Moscow, Russia
基金
俄罗斯科学基金会;
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
0427
引用
收藏
页码:241 / 241
页数:1
相关论文
共 43 条
  • [41] INFLUENCE OF SHORT-TERM INTENSIVE ATORVASTATIN THERAPY ON LYMPHOCYTE AND MONOCYTE SUBPOPULATIONS AND CCR2, CCR5, CX3CR1 AND TLR4 EXPRESSION IN BLOOD OF PATIENTS WITH STABLE ANGINA
    Filatova, Anastasiia
    Kuznetsova, Galina
    Shchinova, Alexandra
    Osokina, Anna
    Potekhina, Alexandra
    Ruleva, Nataliya
    Radukhina, Nataliya
    Noeva, Elena
    Provatorov, Sergey
    Arefieva, Tatiana
    Matrynyuk, Tamila
    ATHEROSCLEROSIS, 2017, 263 : E112 - E113
  • [42] A patient with stage IV type 4 advanced gastric cancer who had a complete pathological response to short-term treatment with S-1 alone
    Ishido, Kenji
    Koizumi, Wasaburo
    Tanabe, Satoshi
    Higuchi, Katsuhiko
    Sasaki, Tohru
    Katada, Chikatoshi
    Azuma, Mizutomo
    Salgenji, Katsunori
    Futawatari, Nobue
    Saegusa, Makoto
    ANTI-CANCER DRUGS, 2008, 19 (09) : 921 - 925
  • [43] During an ongoing pandemic of severe acute respiratory syndrome coronavirus 2, main question which has arisen in everyone's mind is about the immune response that may protect from reinfection. Coronaviruses are known for short-term immunity. Their ability of mutations enables them to escape host immunity, thus increasing chances of reinfection. Here we report two cases of reinfection among health care workers who presented with symptoms of COVID-19 disease, after 3 months of first infectious course. Such documentations are necessary for epidemiological purposes and also to monitor response of virus on re-exposure. © 2021 The Authors. Published by Elsevier Ltd.
    Ahmed, A.
    Sana, F.
    Ikram, A.
    Yousaf, S.
    Khan, A.
    NEW MICROBES AND NEW INFECTIONS, 2021, 42